Skip to main content

Table 1 Baseline characteristics and model-predicted release costs for current and future release areas. Prices are in present value 2018 USD. Figures in brackets represent 95% uncertainty intervals. All costs are discounted at 3% per annum. Accel. denotes accelerated; Seq. denotes sequenced

From: The cost-effectiveness of controlling dengue in Indonesia using wMel Wolbachia released at scale: a modelling study

 

Existing area

Candidate sites

 

Yogyakarta City

Yogyakarta SAR

Jakarta

Bali

Residents (millions)

0.46

3.24

11.19

4.08

Percentage of people covered by Wolbachia

100

65.9

100

59.7

Area (km2)

37.24

3666.21

764.48

6476.03

Percentage of area eligible for Wolbachia

100

24.8

99.9

14.9

Density in covered area (persons/km2)

12,351

2352

14,647

2532

Total cost (US$ millions)

Accel.

Seq.

Accel.

Seq.

Accel.

Seq.

Accel.

5.84 (5.81–5.87)

27.41 (27.37–27.45)

30.68 (30.65–30.73)

83.33 (83.22–83.49)

133.30 (133.14–133.49)

34.88(34.81–34.93)

51.66 (51.57–51.72)

Cost per person covered

12.70 (12.63–12.77)

12.83 (12.81–12.85)

14.36 (14.35–14.38)

7.45 (7.44–7.46)

11.92 (11.90–11.93)

14.32 (14.29–14.34)

21.21 (21.17–21.23)